#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cushing's syndrome Mantle cell lymphoma recurrent Glomerulonephritis minimal lesion Congenital leptin deficiency Human papilloma virus immunisation Retinopathy proliferative Restless legs syndrome Hepatic cirrhosis Hypersensitivity pneumonitis Myelodysplastic syndrome Alpha-1 antitrypsin deficiency Thrombocytopenia Germ cell cancer Postprandial hypoglycaemia Idiopathic inflammatory myopathy More trials…

    Learn about Rare Diseases

    Urea cycle disorder – Trials in Disease Familial amyotrophic lateral sclerosis – Basic Information Rett syndrome – Life with Disease Rhabdomyosarcoma recurrent – Treatment Primary hyperoxaluria – Basic Information Glomerulonephritis membranoproliferative – Basic Information Glycogen storage disease type I Krabbe’s disease – Basic Information Glycogen storage disease type II – Diagnostics Pelizaeus-Merzbacher disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    LVT-001 Rifapentine Pentixafor Gallium Ga-68 Befiradol (18F) Zanubrutinib Nepafenac Brexpiprazole Litenimod Sodium Nizatidine Itacitinib Tropicamide Ltx-315 Tamoxifen Tiaprofenic Acid Rapcabtagene Autoleucel Sabatolimab Vibosameran Phenylephrine Hydrochloride Namilumab Nirogacestat Hydrobromide More therapies…

    Learn about Your Condition

    Pancreatic carcinoma recurrent Plasmablastic lymphoma Proteus syndrome Cutibacterium acnes infection BRAF gene mutation Vertigo Neurofibromatosis Breast cancer stage IV Cancer fatigue Hairy cell leukaemia Bone metabolism disorder Mucopolysaccharidosis III Chorea Periarthritis Traumatic pain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Slovenia

  • A Study of Puxitatug Samrotecan Compared to Chemotherapy for Patients with Advanced Endometrial Cancer After Previous Platinum and Immunotherapy Treatment

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Azd8205
    • Doxorubicin
    • Paclitaxel
    Austria Belgium Czechia Denmark Finland France +9
  • A Study of Gene Replacement Therapy for Children with CTNNB1 Syndrome Using Adeno-Associated Viral Vector Serotype 9 Containing the Human CTNNB1 Gene

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neurodevelopmental disorder
    Investigated Drugs:
    • ADENO-ASSOCIATED VIRAL VECTOR SEROTYPE 9 CONTAINING THE HUMAN CTNNB1 GENE
    Slovenia
  • A Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse

    Recruiting

    2 1
    Investigated Diseases:
    • Chronic inflammatory demyelinating polyradiculoneuropathy
    Investigated Drugs:
    • IMEROPRUBART
    Austria Belgium Bulgaria Denmark Estonia Finland +13
  • A study evaluating the effects of intravenous lidocaine on pain control and recovery after colon cancer surgery

    Recruiting

    2 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Lidocaine Hydrochloride Monohydrate
    • Sodium Chloride
    Slovenia
  • Study of Mezagitamab in Adults with Primary IgA Nephropathy (Berger’s Disease) to Reduce Protein in Urine

    Recruiting

    3 1
    Austria Czechia France Germany Hungary Italy +6
  • Study of Dapagliflozin for Reducing Cardiovascular Events in Adults with High Blood Pressure

    Recruiting

    3 1 1
    Investigated Drugs:
    • Dapagliflozin
    Austria Germany Italy Portugal Slovenia Spain
Previous Page
1 2 3 4 … 17
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Sodium Chloride Lutikizumab Risankizumab Vincristine Sulfate Cyclophosphamide Empasiprubart Dazodalibep Pembrolizumab Semaglutide Guselkumab Atezolizumab Iptacopan Carboplatin Somatropin Cisplatin Bhv-7000 Efanesoctocog Alfa Human Normal Immunoglobulin (Iv) Etoposide Dapagliflozin Inclisiran Doxorubicin Methylprednisolone Sodium Succinate Rocatinlimab 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol Ocrelizumab Bi 1015550 Temozolomide Vedolizumab Golimumab Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acquired antithrombin III deficiency Acute myeloid leukaemia Acute myocardial infarction Amyotrophic lateral sclerosis Anal incontinence Antibiotic therapy Arteriosclerosis Asthma Atypical haemolytic uraemic syndrome B-cell type acute leukaemia Breast cancer Cardiac failure Cardiogenic shock Chronic inflammatory demyelinating polyradiculoneuropathy Colitis ulcerative Colon cancer Critical illness Crohn's disease Cytomegalovirus infection Dementia Alzheimer's type Dermatitis atopic Duchenne muscular dystrophy Endocrine ophthalmopathy Endometrial cancer Endometrial cancer metastatic Erythema migrans Factor IX deficiency Factor VIII deficiency Fallopian tube cancer Glycogen storage disease type II Growth hormone deficiency Heparin resistance Hepatocellular carcinoma Hidradenitis Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-dependent prostate cancer Human epidermal growth factor receptor negative Hyperlipidaemia Hypertension Idiopathic pulmonary fibrosis IgA nephropathy Interstitial lung disease Kidney transplant rejection Malignant glioma Malignant melanoma Multifocal motor neuropathy Multiple sclerosis Multiple sclerosis relapse Myocarditis Myocarditis post infection Neonatal alloimmune thrombocytopenia Neuroblastoma Neurodevelopmental disorder Non-small cell lung cancer Non-small cell lung cancer stage III Noonan syndrome Obesity Ovarian cancer Pancreatic carcinoma metastatic Partial seizures Phenylketonuria Plasma cell myeloma refractory Prostate cancer Psoriatic arthropathy Pulmonary embolism Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Rhabdomyosarcoma Secondary progressive multiple sclerosis Short stature Sjogren's syndrome Small for dates baby Squamous cell carcinoma of head and neck Turner's syndrome Type 1 diabetes mellitus Type 2 diabetes mellitus Type IIa hyperlipidaemia Vascular malformation Viral myocarditis

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!